FAVIPIRAVIR IN HOSPITALIZED COVID-19 PATIENTS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Naveed, Aiman [1 ]
Cheema, Huzaifa [1 ]
Shahid, Abia [1 ]
Singh, Harpreet [2 ]
Kurman, Jonathan [2 ]
Rehman, Mohammad Ebad Ur [3 ]
Umer, Mohammad [1 ]
Sahra, Syeda [4 ]
Ahmad, Faran [5 ]
Ahmad, Sharjeel [6 ]
机构：
[1] King Edward Med Univ, Lahore, Pakistan
[2] Med Coll Wisconsin, Milwaukee, WI USA
[3] Rawalpindi Med Univ, Rawalpindi, Pakistan
[4] Univ Oklahoma, Hlth Sci Ctr, Norman, OK USA
[5] Creighton Univ, Omaha, NE USA
[6] Univ Illinois, Coll Med, Dept Med, Infect Dis Sect, Peoria, IL USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
30
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Enoxaparin for COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Ehsan, Muhammad
    Jafar, Uzair
    Butt, Momina
    Naveed, Aiman
    Umer, Mohammad
    Ayyan, Muhammad
    Mustafa, Biah
    Awan, Rehmat Ullah
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 495 - 498
  • [32] Renin-angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
    Kow, Chia Siang
    Ming, Long Chiau
    Hasan, Syed Shahzad
    HYPERTENSION RESEARCH, 2021, 44 (08) : 1042 - 1045
  • [33] Efficacy of omega-3 fatty acids for hospitalized COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials
    Yue, Han-yang
    Zeng, Jun
    Wang, Yu
    Deng, Meng-jie
    Peng, Wei
    Tan, Xin
    Jiang, Hua
    ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2023, 32 (03) : 308 - 320
  • [34] The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials
    Kow, Chia Siang
    Ramachandram, Dinesh Sangarran
    Hasan, Syed Shahzad
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (02) : 257 - 265
  • [35] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
    Toshie Manabe
    Dan Kambayashi
    Hiroyasu Akatsu
    Koichiro Kudo
    BMC Infectious Diseases, 21
  • [36] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
    Manabe, Toshie
    Kambayashi, Dan
    Akatsu, Hiroyasu
    Kudo, Koichiro
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [37] Does methylprednisolone reduce the mortality risk in hospitalized COVID-19 patients? A meta-analysis of randomized control trials
    Hasan, Syed Shahzad
    Kow, Chia Siang
    Mustafa, Zia Ul
    Merchant, Hamid A.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (08) : 1049 - 1055
  • [38] Hydroxychloroquine for Non-Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Lucchetta, Rosa
    Matuoka, Jessica Y.
    de Oliveira Junior, Haliton Alves
    Oliveira, Gustavo
    Cavalcanti, Alexandre Biasi
    Azevedo, Luciano
    Berwanger, Otavio
    Lopes, Renato Delascio
    Rosa, Regis Goulart
    Veiga, Viviane Cordeiro
    Avezum, Alvaro
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2023, 120 (04)
  • [39] Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
    Sagris, Dimitrios
    Florentin, Matilda
    Tasoudis, Panagiotis
    Korompoki, Eleni
    Gatselis, Nikolaos
    Giamarellos-Bourboulis, Evangelos J.
    Milionis, Haralampos
    Douketis, James
    Spyropoulos, Alex C.
    Dalekos, George
    Ntaios, George
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [40] Convalescent plasma therapy for COVID-19 patients: a protocol of a prospective meta-analysis of randomized controlled trials
    Szako, Lajos
    Farkas, Nelli
    Kiss, Szabolcs
    Vancsa, Szilard
    Zadori, Noemi
    Vorhendi, Nora
    Eross, Balint
    Hegyi, Peter
    Alizadeh, Hussain
    TRIALS, 2021, 22 (01)
12345